Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
about
Management of aggressive growth hormone secreting pituitary adenomas.Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1.The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessClinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Presence of sst5TMD4, a trunca ...... creatic neuroendocrine tumors.
@en
type
label
Presence of sst5TMD4, a trunca ...... creatic neuroendocrine tumors.
@en
prefLabel
Presence of sst5TMD4, a trunca ...... creatic neuroendocrine tumors.
@en
P2093
P2860
P50
P356
P1433
P1476
Presence of sst5TMD4, a trunca ...... ncreatic neuroendocrine tumors
@en
P2093
Alicia Villa-Osaba
Ana M Ramos-Levi
Ana Serrano-Somavilla
Miguel Sampedro-Núñez
Mónica Marazuela
P2860
P304
P356
10.18632/ONCOTARGET.6565
P407
P50
P577
2016-02-01T00:00:00Z